Genetic test for predicting weight loss drug response
Part of Hormones & metabolism clinical trials.
This trial looks at whether your genes can predict how well you will respond to weight loss medications like semaglutide (Wegovy/Ozempic) or tirzepatide (Mounjaro). It may help doctors choose the right drug for you based on your DNA.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- Your body mass index (BMI) is 40 or higher, or 37 or higher with a related health problem like diabetes or high blood pressure
- You are about to start taking semaglutide or tirzepatide for weight loss
- You have not had weight loss surgery before
- You do not have a history of certain cancers or pancreatitis
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-stage study looks at how genetic factors may change how people respond to a GLP-1 medicine (semaglutide). The goal is to learn who may benefit most and why, so future treatments can be better matched.
This study looks at how a weight-loss medication affects people with obesity who may have a specific gene difference (caveolin-1). It aims to understand why some people respond differently to GLP-1 treatments like semaglutide.
This study looks at how genetics may affect your body’s early response to oral semaglutide, a weight-related diabetes medicine. You may be considered if you are overweight (or overweight with prediabetes) and can safely take part in the research.
This trial looks at how two weight-loss medications, semaglutide and tirzepatide, affect your body's fat and muscle. It may help you understand if these medications improve your overall health beyond just weight loss.
This study looks at how weight loss medications (semaglutide or tirzepatide) affect your appetite and the hormones that control it. The goal is to better understand why these medicines help people lose weight.
This study tests a medication called semaglutide (which helps with weight loss) in people with obesity who have struggled to lose weight before. It will see how much weight participants can lose while taking the drug.
Hear when a new Obesity (Disorder) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.